Clinical Trial Update: To Assess the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes Mellitus Treated With Empagliflozin

View source ↗

Summary

A completed clinical trial evaluated whether empagliflozin alters the risk of acute pancreatitis in adults with Type 2 diabetes mellitus; results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (Jardiance) (empagliflozin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED | Results posted: 2024-03-18